Patent · US Active

Naphthalene-containing melanocortin receptor-specific small molecule

US7732451B2 · kind B2 · utility

3Cited by

90References

15Claims

0Family size

Assignee

Palatin Technologies, Inc. · US

Inventors

Shubh D. Sharma · Cranbury, US
Annette Shadiack · Somerville, US
Yiqun Shi · East Brunswick Township, US
Zhijun Wu · Plainsboro, US
Ramesh Rajpurohit · Fryeburg, US
Kevin D. Burris · Washington Crossing, US
Papireddy Purma · Plainsboro, US

Key dates

Filing date	Jan 14, 2005
Grant date	Jun 8, 2010
Priority date	—
Expiry date	Jan 13, 2028

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K31/496
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A method of modulating energy homeostasis in a mammal without eliciting a sexual response by administration of a therapeutically effective amount of a pharmaceutical composition including a melanocortin receptor compound of the formula:where R1 is a bond or a linker unit including from one to six backbone atoms and an unsubstituted naphthalene group, and L, R2, R3 and Rx are as defined in the specification.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.